Sentences with phrase «for growth and development in»

Many developers are reaching beyond their traditional market areas — seeking opportunities for growth and development in new territories.

While it's best to start self - esteem building young, there is still tons of room for growth and development in this area for middle and high schoolers.

SOKUNTHEA SUOS 2145 Chapman Drive Carrollton, Texas 75010 [email protected] OBJECTIVE: I am currently seeking a position that utilizes my skills and experiences with a company that provide opportunity for growth and development in the future.

Looking for growth and development in a caring professional atmosphere that encourages collaboration, excellence and innovation.

There may be more room for growth and development in a smaller set - up than in a multinational company.

Beef is a key source of energy, and is important for growth and development in dogs.

Salmon is a key source of energy, and is important for growth and development in dogs.

Pork is a key source of energy, and is important for growth and development in dogs.

Protein is a key source of energy, and is important for growth and development in cats.

Turkey is a key source of energy, and is important for growth and development in dogs.

The Chief Academic Officer (CAO) will coordinate, define, and communicate integrated plans for the growth and development in all educational areas.

Additionally, Jennifer offers a more targeted leadership and executive coaching for savvy career women seeking to maximize their opportunities for growth and development in the workplace.

Aside from regulating your metabolism and weight by controlling the fat - burning process, thyroid hormones are also required for the growth and development in children and in nearly every physiological process in your body.

Proteins supply energy, but the primary role of protein in the diet is for healing injured tissue and for growth and development in the body.

WE KNOW they are vital for growth and development in plants and worms, and now it seems that small pieces of RNA called microRNAs also play a key role in mammals.

Feeding interventions for growth and development in infants with cleft lip, cleft palate or cleft lip and palate.

HiPP Organic Combiotic growing up milk contains all of these nutrients essential for growth and development in the right quantities for your child.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

But for Boeing in particular, growth brings innovation, supported by the company's $ 6 billion budget for research and development.

To some extent launching a successful Kickstarter project takes care of marketing and sales in addition to generating cash for product development or investment in growth initiatives.

Employment and Social Development Canada projects slow - and - steady growth in employer demand for these positions through 2022.

But the finance function is transforming from being known for saying «no» to big projects to taking a role in growth and development.

«Infrastructure development will help improve connectivity within the city and bodes well for the real estate projects coming in the suburbs and MMR region which will further spur growth of the sector», according to Chintan Sheth from Sheth Corp..

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

«We thank John for his important contributions during this high - growth stage of our development, and wish him the very best in his future endeavors,» said company chairman Chris Blisard.

«With Ablynx, we continue to advance the strategic transformation of our research and development, expanding our late - stage pipeline and strengthening our platform for growth in rare blood disorders,» Sanofi Chief Executive Officer Olivier Brandicourt said.

Rankings are based on four criteria: employment growth (25 %), median compensation (based on a 40 - hour workweek) in 2013 (40 %), the change in median compensation from 2007 — 08 to 2012 — 13 (10 %), and projected demand for those jobs using data from Human Resources and Skills Development Canada (25 %).

Kostin also outlined three strategies: Secular growth, or companies where sales growth is expected to rise at least 10 percent for multiple years without high valuations; firms that are investing in capital expenditures and research and development; and companies with a strong chance to be acquired.

«For the remainder of 2014 we will focus on our multi-layered growth strategy, which incorporates same - store sales growth, leverage from higher sales, deployment of free cash flow, increasing royalty revenues and new drive - in development to build shareholder value,» Sonic CEO Cliff Hudson said in a statement.

They need to know what's in it for them, their own growth and their personal development — not just how it will benefit the institution.»

The Memphis City Council voted on Oct. 3 to offer the tax breaks for the company's headquarters, possibly in addition to incentives from the development agency Economic Development Growth Engine, Shelby County anddevelopment agency Economic Development Growth Engine, Shelby County andDevelopment Growth Engine, Shelby County and the state.

These recommendations were in fact cited by the Organisation for Economic Co-operation and Development (OECD) in its 2016 annual Economic Survey of Canada.Naming a lack of productivity as a major impediment to future economic growth, the OECD called for Canada to pursue a platform of deregulation while also reducing interprovincial trade barriers and providing more incentives for small - and medium - sized companies to innovate and invest.

While Google's arsenal of perks — which includes everything from «stock equity,» to «free 24/7 gym access,» «aaaaaamazing holiday parties,» and «mini-kitchens, snacks, drinks, free breakfast / lunch / dinner, all day, errr «day» — are notoriously cushy, the company wins real points with employees for attracting «the best talent and best people to work with in the world» as well as providing abundant «opportunities for career growth, and tons of career development resources.»

An Organization for Economic Cooperation and Development report a few years ago concluded that «a key cause of the underlying fall in manufacturing employment everywhere is rapid productivity growth, whether by restructuring inefficient plants or deploying skills, knowledge, technology and new processes to boost efficiency.»

«There seems to be a genuine concern for the growth and development of people in the organization.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Companies use corporate venture capital as a compelling means to drive outside - in («open») innovation for: access to new and disruptive technologies, the development of new business models and participation in emerging markets, all of which may provide meaningful contributions to corporate growth.

If policy developments in advanced economies make the path for growth and debt less benign than expected, risk premiums and volatility could rise sharply.

Mr. Barrett joined the Firm's predecessor in 1989 and has overseen GCP's growth since its inception, including its expansion into the secondary market for private equity and the development of its institutional investor base.

While it's always interesting to know about the top runners, renewable energy companies in various growth stages will become more important as government funding for research and development related to energy efficient, emissions reduction and carbon capture decreases.

A government - affiliated organization in China has announced that, in line with the country's current «five - year plan» for economic growth, it will establish an organization to promote blockchain investment and development.

Since our last MPR in April, global economic developments have been quite disappointing, and these have led to a significant downgrade of our estimate of Canadian economic growth for 2015.

We have made significant investments in the development of these buyer - facing products and services, and our ability to grow our buyer network will be important for strengthening our ecosystem and driving our growth.

The organization cited St. Louis» BioSTL bioscience economic development coalition — established in 2001 to build on plant and life science strengths — as a model for cities endeavoring to create economic growth through regional strengths.

After eighteen months and a significant capital investment in research, and development, Bellwether launched a series of investment solutions based on our «Disciplined Dividend Growth» investment process for affluent investors.

Ragatz is stepping into a two-fold role: In addition to making investments, she's in charge of growth and development for the firm itselIn addition to making investments, she's in charge of growth and development for the firm itselin charge of growth and development for the firm itself.

Critics contend that's bad for innovation and growth because sending money back to shareholders reduces investments in equipment, technology and research and development, and lowers corporate spending and aggregate demand for goods and services.

In recent years, the Netherlands has experienced a string of positive developments in its startup ecosystem, positioning the country — and its entrepreneurial core, the StartupDelta - Amsterdam region — for even more growtIn recent years, the Netherlands has experienced a string of positive developments in its startup ecosystem, positioning the country — and its entrepreneurial core, the StartupDelta - Amsterdam region — for even more growtin its startup ecosystem, positioning the country — and its entrepreneurial core, the StartupDelta - Amsterdam region — for even more growth.

Washington, D.C. — The Women's Business Enterprise National Council (WBENC), the nation's leader in women's business development, today announced the 16th Annual America's Top Corporations for Women's Business Enterprises (WBEs), the only national award honoring corporations and their leadership for choosing to integrate policies and programs to enable growth and reduce barriers for women - owned businesses.

Written by NCEO founder Corey Rosen, this issue brief discusses as of mid-2016 the extent and growth of employee ownership; survey data on ESOPs and corporate governance as well as ESOPs and executive compensation; research on the effect of ESOPs on corporate performance; the 2012 shared capitalism study of Great Place to Work applicants; data on employee ownership and employee financial well - being; the NCEO's analysis of data on ESOPs and default rates; trends in broad - based equity compensation plans; equity compensation and corporate performance; the impact of ESOPs and other broad - based plans on unemployment; legislative and regulatory issues for employee ownership; and international developments in broad - based plans.